Cargando…
An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids
Low dose metronomic chemotherapy (LDMC) refers to prolonged administration of low dose chemotherapy designed to minimize toxicity and target the tumor endothelium, causing tumor growth inhibition. Topotecan (TPT) when administered at its maximum tolerated dose (MTD) is often associated with systemic...
Autores principales: | Jyoti, Amar, Fugit, Kyle D., Sethi, Pallavi, McGarry, Ronald C., Anderson, Bradley D., Upreti, Meenakshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606561/ https://www.ncbi.nlm.nih.gov/pubmed/26468877 http://dx.doi.org/10.1038/srep15236 |
Ejemplares similares
-
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2023) -
Dynamic, Nonsink Method for the Simultaneous Determination
of Drug Permeability and Binding Coefficients in Liposomes
por: Fugit, Kyle D., et al.
Publicado: (2014) -
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers
por: Mitra Ghosh, Taraswi, et al.
Publicado: (2023) -
Optimization of liposomal topotecan for use in treating neuroblastoma
por: Chernov, Lina, et al.
Publicado: (2017) -
Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer
por: Mitra Ghosh, Taraswi, et al.
Publicado: (2021)